Ajani J A, Carrasco C H, Charnsangavej C, Samaan N A, Levin B, Wallace S
Department of Medical Oncology, University of Texas M. D. Anderson Hospital and Tumor Institute, Houston.
Ann Intern Med. 1988 Mar;108(3):340-4. doi: 10.7326/0003-4819-108-3-340.
The value of sequential percutaneous hepatic artery embolization with polyvinyl alcohol particles was examined in 22 patients with islet cell carcinoma metastatic to the liver. Nine patients had gastrinoma, 2 had glucagonoma, and 11 had no discernible hormonal secretions or syndromes. Ninety-seven embolizations were done with a median number of 4 (range, 1 to 12) per patient. The interval between embolizations ranged from 1 to 8 months. Twelve of twenty evaluable patients had a partial remission, frequently associated with subjective improvement and decrease in hormone levels. The projected median survival of all 22 patients from the initiation of embolization is 33.7 months (range, 1 to 72). Nausea, vomiting, fever, and abdominal pain occurred with each embolization and subsided usually by day 10 (range, 3 to 35). Sequential hepatic artery occlusion is an effective method for prolonged palliation in this selected group of patients.
对22例胰岛细胞癌肝转移患者进行了聚乙烯醇颗粒序贯经皮肝动脉栓塞术的疗效评估。其中9例为胃泌素瘤,2例为胰高血糖素瘤,11例无明显激素分泌或综合征。共进行了97次栓塞,每位患者的栓塞次数中位数为4次(范围1至12次)。栓塞间隔时间为1至8个月。20例可评估患者中有12例部分缓解,常伴有主观症状改善和激素水平下降。所有22例患者自开始栓塞起的预计中位生存期为33.7个月(范围1至72个月)。每次栓塞均出现恶心、呕吐、发热和腹痛,通常在第10天(范围3至35天)消退。序贯肝动脉闭塞术是延长这部分特定患者缓解期的有效方法。